$1,070,000 of CARDINAL HEALTH INC lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, behavioral health, food is medicine, acute hospital care at home waiver; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, pandemic preparedness, and product shortages. Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation bottlenecks. Issues related to tax reform and 2017 Tax Cuts and Jobs Act. Issues related to tariffs, trade, and U.S. trade policy. Issues related to tariffs, trade, and U.S. trade policy."
You can find more data on corporate lobbying on Quiver Quantitative.
CAH Congressional Stock Trading
Members of Congress have traded $CAH stock 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CAH stock by members of Congress over the last 6 months:
- REPRESENTATIVE MARJORIE TAYLOR GREENE has traded it 2 times. They made 2 purchases worth up to $30,000 on 03/17, 01/21 and 0 sales.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
CAH Insider Trading Activity
CAH insiders have traded $CAH stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CAH stock by insiders over the last 6 months:
- MARY C. SCHERER (Chief Accounting Officer) sold 3,504 shares for an estimated $432,919
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CAH Hedge Fund Activity
We have seen 494 institutional investors add shares of CAH stock to their portfolio, and 461 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PACER ADVISORS, INC. removed 4,254,464 shares (-99.2%) from their portfolio in Q4 2024, for an estimated $503,175,457
- MILLENNIUM MANAGEMENT LLC added 2,608,333 shares (+331.1%) to their portfolio in Q4 2024, for an estimated $308,487,543
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 2,382,566 shares (-77.4%) from their portfolio in Q4 2024, for an estimated $281,786,080
- ELLIOTT INVESTMENT MANAGEMENT L.P. removed 2,000,000 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $236,540,000
- MARSHALL WACE, LLP added 1,913,892 shares (+154.6%) to their portfolio in Q4 2024, for an estimated $226,356,006
- CITADEL ADVISORS LLC added 1,530,044 shares (+92.0%) to their portfolio in Q4 2024, for an estimated $180,958,303
- AMERIPRISE FINANCIAL INC removed 1,298,199 shares (-44.2%) from their portfolio in Q4 2024, for an estimated $153,537,995
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CAH Analyst Ratings
Wall Street analysts have issued reports on $CAH in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Cowen & Co. issued a "Buy" rating on 01/31/2025
- Evercore ISI issued a "Outperform" rating on 01/07/2025
To track analyst ratings and price targets for CAH, check out Quiver Quantitative's $CAH forecast page.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
